Skip to service details
Advanced Platforms

Antibody-Drug Conjugates (ADC)

Connect antibody discovery, linker-payload chemistry, conjugation, and validation in an integrated ADC research program.

  • Linker chemistry
  • Site-specific conjugation
  • In-vivo validation

The science

Service overview

We offer comprehensive antibody-drug conjugate (ADC) services, including antibody discovery, linker-payload design and synthesis, and ADC conjugation, as well as in-vitro and in-vivo validation studies.

How we can help

Our capabilities

Explore the services and methods available for your project.

Explore in detail

Technical resources

Open a section to explore our full service scope and instrumentation.

Methods & service scope7 areas of expertise
  • Strategic Consultation & Discovery Planning
  • Target Identification & Therapeutic Candidate Screening
  • Custom Conjugate Design & Linker-Payload Optimization
  • Proof of Concept (POC) Studies & Lab-Scale Synthesis
  • In-Vitro & In-Vivo Validation Studies
  • Preclinical Development & Advanced Bioassays
  • Regulatory Support & IND Application
Instrumentation & platforms5 instruments and capabilities
  • Advanced Linker Chemistry
  • AI-Driven ADC Design and Discovery
  • Site-Specific Conjugation Technologies
  • Advanced Antibody Discovery Platforms
  • Analytical Tools for ADC Characterization (i.e., SEC-MALS, UPLC-MS/MS, RP-HPLC, CE)

Let’s work together

The right expertise.
For your next step.

Talk with our scientific team about your requirements,
technical feasibility, and timelines.

What happens next

  1. Share your requirementsTell us about your research goals, scope, and timelines.
  2. Scientific consultationOur scientists review feasibility and discuss the best approach with you.
  3. Proposal and quoteReceive a clear proposal covering scope, deliverables, timelines, and cost.